Compare Quant Healthcare Fund vs SBI Healthcare Opportunities Fund
Quant Healthcare Fund
SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹1000
₹500
Expense Ratio
3.14
2.01
NAV
₹17.61
₹574.88
Fund Started
27 Jun 2023
04 Jun 1999
Fund Size
₹391.06 Cr
₹4997.72 Cr
Exit Load
Exit load of 1%, if redeemed within 15 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
7.62%
12.39%
3 Year
18.71%
22.49%
5 Year
-
15.98%
Equity
95.20%
97.16%
Cash
-2.06%
2.78%
Top 10 Holdings
HFCL Ltd. | 10.76% |
Zydus Wellness Ltd. | 9.44% |
Aster DM Healthcare Ltd. | 8.96% |
Concord Biotech Ltd. | 8.84% |
Glenmark Pharmaceuticals Ltd. | 8.70% |
SMS Pharmaceuticals Ltd. | 8.15% |
Alivus Life Sciences Ltd | 7.28% |
Max Healthcare Institute Ltd. | 5.80% |
Divi's Laboratories Ltd. | 5.74% |
Pfizer Ltd. | 5.44% |
Sun Pharmaceutical Industries Ltd. | 11.18% |
Acutaas Chemicals Ltd. | 6.35% |
Divi's Laboratories Ltd. | 5.92% |
Apollo Hospitals Enterprise Ltd. | 5.21% |
Max Healthcare Institute Ltd. | 5.08% |
Aurobindo Pharma Ltd. | 4.17% |
Aster DM Healthcare Ltd. | 3.77% |
Laurus Labs Ltd. | 3.64% |
Cipla Ltd. | 3.52% |
Torrent Pharmaceuticals Ltd. | 3.33% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
27 Jun 2023
04 Jun 1999
